Home » Screening and Intervention Programs » Project Directory » Southern California Alcohol and Drug Programs, Inc. (SCADP)
Southern California Alcohol and Drug Programs, Inc. (SCADP)
FASD Prevention Subcontractors
(Parent-Child Assistance Program)
Project Contact Information
Southern California Alcohol and Drug Programs, Inc. (SCADP)
Elizabeth Stoltz, MFA, Program Director
11500 Paramount Boulevard
Downey, CA 90241
Project Summary Statement
The SCADP PCAP program (Southern California Alcohol and Drug Program’s Parent-Child Assistance) is one of two Parent-Child Assistance Programs funded as a Fetal Alcohol Spectrum Disorder (FASD) prevention initiative through the FASD Center for Excellence.
SCADP is a multi-site, community based, nonprofit organization founded in 1972 with a mission to provide treatment for addiction and other related problems to underserved populations in Los Angeles and Orange Counties. Our continuum of care includes a static capacity of 500 residential addiction treatment beds with four hundred of those beds dedicated to pregnant and parenting women and their children. The agency currently serves a minimum of 1500 women each year who are at risk for giving birth to a child with an FASD.
PCAP is an intensive three year home visitation intervention for pregnant and parenting, alcohol abusing mothers who have completed a 4-6 month residential addiction treatment program in one of our facilities in Los Angeles or Orange Counties. Each PCAP advocate works with sixteen women, her alcohol exposed infant (the target child) and their extended family, visiting their home every ten days throughout the three years. Women are referred to the program by the program directors from one of SCADP’s twelve residential or two outpatient women’s addiction treatment programs. Women are screened for the program by PCAP advocates. Participating women must be either pregnant or up to 6 months postpartum with the target child exposed to alcohol in vivo. The Clinical Supervisor welcomes each participant and administers a PCAP modified Addiction Severity Index) ASI before assigning the woman to her advocate.
The relationship between the advocate and participant begins with an individual needs assessment resulting in the development of a set of personal goals. Together, advocate and participant work on participant’s goal achievement with regular reassessment and unwavering support throughout the three years.
PCAP was developed in Seattle, Washington by Therese Grant, an etiologist at the University of Washington Medical School. Dr. Grant personally trained the SCADP PCAP team at the outset of the program in September, 2008. The program is based on the core beliefs that FASD is 100% preventable and that “a woman’s sense of connectedness to others is central to her own growth and development.” PCAP offers an opportunity for a long term relationship that will build confidence in a participant’s ability to develop skills to discern and maintain healthy connections with community, family and friends.
SCADP PCAP enrolled the first clients in August, 2008, after a six month planning and preparation period during which staff was hired and trained and the agency prepared to integrate the program into the existing service delivery system. Clients were enrolled into the program as planned throughout the first program year. Thirty three (33) clients have been enrolled in the program since inception. One client has been discharged for lack of participation. The original PCAP staffing pattern maintained three advocates, one full time for LA County and two part- time in Orange County. After the first year, advocacy staff was condensed to two full time advocates. The initiative has three goals:
- To achieve abstinence from alcohol while pregnant and postpartum;
- To increase use of effective methods of contraception;
- To prevent future alcohol-exposed pregnancies.
The Outcome and Process objectives, as follows, were designed to support achievement of the initiative goals: Outcome objectives:
- Achieve abstinence from alcohol
- Regain sobriety after relapse
- Use effective contraception consistently
- No alcohol exposed pregnancies
- Access any needed FASD-related or P-CAP identified services in the community via case management, community resource referrals, advocacy and support.
- Maintain 75% completion rate for PCAP participants.
- Provide P-CAP with fidelity to the model as designed by Therese Grant
- Receive training on how to deliver the PCAP intervention model
- Develop PCAP policies and procedures
- Collect required data throughout the duration of the project
- Develop annual project implementation plan for each of the four operating years.
- Maintain an FASD task force
- Develop and implement a P-CAP sustainability pl
Outcomes have shown that the initial objectives relating to alcohol abstinence were met and exceeded. The first outcome objective required 67% of enrolled women remain abstinent from alcohol throughout their first 6 months as PCAP participants. Biannual report data has been entered for 72% (23 out of 32) of the PCAP participants. 22 of the 23 participants have abstained from alcohol throughout their first 6 months of the program. The second objective anticipated that 27 women out of the 32 enrolled may relapse during the three years they’re enrolled in PCAP and that out of those relapsing, 75% of those enrolled in PCAP would regain sobriety. To date, all women with reported relapse have regained sobriety. As of July 31, 2010, 13 out of 25 (52%) postpartum women reporting use effective contraception consistently.
During the first two years of the project, the program has reached 100% enrollment and delivered the intervention to fidelity with periodic supervision calls with Therese Grant. Data has been collected throughout the two years and entered into the Datstat online data collection system as directed by Northrop Grumman. Over the course of the last two years, the advocates have successfully developed and maintained strong and trusting relationships with their clients. The success of the program is largely due to the exceptional dedication of the advocates, Yanira Rivas and Diana Stafford, and the support provided to them by Janet Burtt, the clinical supervisor.